how many americans are taking glp-1 Chart: 1 in 8 Now Use Drugs for Weight Loss New weight-loss drugs surge in

Researchers believe this may be due to a combination of factors, such as inhibiting sugar absorption in the small intestine, promoting glycogen synthesis in the liver, and protecting pancreatic beta cells

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist available in the US under two brand names: Mounjaro (for type 2 diabetes in adults) and Zepbound (for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity)

It establishes a reliable baseline

Biochemical and Biophysical Research Communications 2009

Maintain Hydration: Continue to drink plenty of water after your treatment

GLP-1 receptors exist in brain regions involved in reward, motivation, and eating behavior